Replica Analytics Announces New Funding from Nina Capital

News Release

Replica Analytics has closed a financing round with Nina Capital. This new funding injection will enable Replica Analytics to continue developing our data synthesis technology and expand our capabilities for creating robust simulators and digital twins. The additional funding will allow our team to accelerate innovation and translate these innovations into easy-to-use products. 

Our Replica Analytics team has developed a strong portfolio of machine learning technologies that can work with real-world health data and create generative models based on them, in a very short period.

 

About Nina Capital

Nina Capital is a European, sector-focused firm that invests in health technology companies internationally. They invest in companies who marry an in-depth understanding of healthcare system participants’ complex network with advanced data science and IT-enabled products and services. They aim to support companies determined to effectively and efficiently serve these participants in Europe and internationally.

Share on social: